PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportscachexia
MeSH D002100 - cachexia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D015431:Weight loss
0 Companies
0 Drugs
Success rate
D013851:Thinness
0 Companies
0 Drugs
Success rate
D002100: 
Cachexia
20 Companies
3 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMegestrol Megestrol  1998-02-27   
SandozSomatropin Omnitrope  2006-04-12   
Eli LillySomatropin Humatrope  1986-10-16   
Barr PharmaceuticalsMegestrol Megestrol  1995-11-30   
Strides Pharma GlobalMegestrol Megestrol  1988-08-08   
Bristol Myers SquibbMegestrol Megace  1982-01-01   
TWi PharmaceuticalsMegestrol Megestrol  2014-08-27   
Hikma PharmaceuticalsMegestrol Megestrol  1995-09-29   
Pharmacia & UpjohnSomatropin Genotropin  1995-08-24   
GenentechSomatropin Nutropin  1993-11-17   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
20%
2/10
Phase 2
10%
1/10
Phase 3
21%
3/14
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Eli Lilly
Somatropin
Bristol Myers Squibb
Megestrol,
Megestrol acetate,
Nepidermin,
Nabiximols
Pharmacia & Upjohn
Somatropin
Genentech
Somatropin
Endo
Megestrol,
Megestrol acetate
Novo Nordisk
Somatropin,
SOMATROPIN PEGOL
Ferring Pharmaceuticals
Somatropin
Ipsen
Somatropin,
Bermekimab,
Folinoral
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use